Your browser doesn't support javascript.
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry.
Weiss, Daniel J; Filiano, Anthony; Galipeau, Jacques; Khoury, Maroun; Krampera, Mauro; Lalu, Manoj; Blanc, Katarina Le; Nolta, Jan; Phinney, Donald G; Rocco, Patricia R M; Shi, Yufang; Tarte, Karin; Viswanathan, Sowmya; Martin, Ivan.
  • Weiss DJ; University of Vermont College of Medicine, Burlington, Vermont, USA.
  • Filiano A; Department of Immunology, Duke University, Durham, North Carolina, USA; Marcus Center for Cellular Cures, Duke University, Durham, North Carolina, USA; Department of Pathology, Duke University, Durham, North Carolina, USA; Department of Neurosurgery, Duke University, Durham, North Carolina, USA.
  • Galipeau J; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
  • Khoury M; IMPACT-Center for Interventional Medicine for precision and advanced cellular therapy, Universidad de los Andes, Santiago, Chile; Cells for Cells and Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.
  • Krampera M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Lalu M; Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Regenerative Medicine, Ottawa Hospital Research Institu
  • Blanc KL; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Nolta J; Department of Internal Medicine, Stem Cell Program and Institute for Regenerative Cures, University of California Davis, Sacramento, California, USA.
  • Phinney DG; UF Scripps Biomedical Research, Jupiter, Florida, USA.
  • Rocco PRM; Laboratory of Pulmonary Investigation, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Shi Y; The First Affiliated Hospital, Soochow University Institutes for Translational Medicine, Suzhou, China; Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Tarte K; UMR U1236-MICMAC, Immunology and Cell Therapy Lab, Rennes University Hospital, Rennes, France.
  • Viswanathan S; Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada; Krembil Research Institute, University Health Network, Toronto, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Canada; Department
  • Martin I; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Cytotherapy ; 24(11): 1071-1073, 2022 11.
Article in English | MEDLINE | ID: covidwho-2015637
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Cytotherapy Journal subject: Therapeutics Year: 2022 Document Type: Article Affiliation country: J.jcyt.2022.07.010

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Cytotherapy Journal subject: Therapeutics Year: 2022 Document Type: Article Affiliation country: J.jcyt.2022.07.010